ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilde, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilde, J
Eur Respir J 1989; 2: 656-662
Copyright © ERS Journals Ltd 1989


Original Articles

A 10 year follow-up of semi-annual screening for early detection of lung cancer in the Erfurt County, GDR

J Wilde

A prospective and controlled study for early detection of lung cancer in the county of Erfurt with a follow-up of 10 years is presented. A collective of 41,532 males born between 1907 and 1932 was screened by chest fluorography at 6 month intervals and compared with a control group consisting of 102,348 males of the same age, who were screened at intervals of about 18 months. No significant reduction of overall mortality and of lung cancer mortality was achieved. Semi-annual screening brought about a higher detection rate (9%/6.5%), an increase in the resection rate (28%/19%) and higher 5 and 10 year survival rates (52%; 27%/39%; 19%) of resected patients than screening in 18 month intervals. Among those patients who refused resection or were surgically untreatable, the difference in survival rates between the two investigation groups lasted only up to the 12 months barrier. This is regarded as the effect of the lead-time bias. Fluorographic screening is effective only in patients with peripheral cancers. Patients resected for central lung cancers did not show differences in the survival rates. In both investigation groups considered together surgical therapy was possible mainly in those patients who had been detected by screening (resection rate: 48%; 5 yr survival rate: 26.9%). The resection rate of all the others amounted to 9%, the 5 yr survival rate to 1.4%. Therefore we consider fluorography to time as the only chance for lung cancer control of high risk groups in spite of the absence of reduction of lung cancer mortality.


This article has been cited by other articles:


Home page
ICVTSHome page
I. Hunt, M. Siva, R. Southon, and T. Treasure
Does lung cancer screening with chest X-ray improve disease-free survival?
Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 483 - 487.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. L. Humphrey, S. Teutsch, and M. Johnson
Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force
Ann Intern Med, May 4, 2004; 140(9): 740 - 753.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R L Manser, L B Irving, G Byrnes, M J Abramson, C A Stone, and D A Campbell
Screening for lung cancer: a systematic review and meta-analysis of controlled trials
Thorax, September 1, 2003; 58(9): 784 - 789.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R.J. van Klaveren, J.D.F. Habbema, J.H. Pedersen, H.J. de Koning, M. Oudkerk, and H.C. Hoogsteden
Lung cancer screening by low-dose spiral computed tomography
Eur. Respir. J., November 1, 2001; 18(5): 857 - 866.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
J R C Ellis and F V Gleeson
Lung cancer screening
Br. J. Radiol., June 1, 2001; 74(882): 478 - 485.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
E. F. Patz, P. C. Goodman, and G. Bepler
Screening for Lung Cancer
N. Engl. J. Med., November 30, 2000; 343(22): 1627 - 1633.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the European Respiratory Society.